VacHeal, LLC appears in FDA device records as the applicant behind a single premarket notification, K254160, for the VacHeal Negative Pressure Wound Therapy System. The filing was received on 2025-12-22 and decided on 2026-09-18 with decision code SESE, described as Substantially Equivalent. The record places the device in product code OKO, regulation 878.4683, device class 2, with the review panel listed as General, Plastic Surgery. [1][2][4]
The documented product and its classification
The device named in the filing is the VacHeal Negative Pressure Wound Therapy System. FDA data classify it as a Negative Pressure Wound Therapy Non-Powered Suction Apparatus, product code OKO, under 21 CFR 878.4683, device class 2. The advisory committee and review panel are both recorded as General, Plastic Surgery, and the clearance type is Traditional. A TPLC listing describes a non-powered suction apparatus indicated for negative pressure wound therapy intended for wound management via application of negative pressure. [1][4][5]
The submission carried a Summary rather than a statement, and the third-party review flag is recorded as N, meaning the review was not conducted by an accredited third party. The FDA 510(k) database page for K254160 shows the control plan authorized field as No. No performance data, component list or shelf-life information appears in the numbered records. [1][2][4]
Submission timeline and review path
The 510(k) was received by FDA on 2025-12-22 and cleared on 2026-09-18, a review span of roughly nine months. The decision code SESE corresponds to Substantially Equivalent, and the decision description in the record reads the same. The expedited review flag field is empty in the record, so no expedited status is documented. [1][4]
The FDA 510(k) database page for this notification carries a page update date of 11/09/2026, and a TPLC entry referencing K254160 is dated Sep 21, 2026. These dates describe when the public records were refreshed, not additional regulatory milestones. No supplemental filings, premarket approval or de novo classification for this applicant appear in the numbered sources. [2][5]
Applicant identity and what the records do not establish
VacHeal, LLC is recorded as the applicant on K254160. The FDA record lists an address in Ardmore, Pennsylvania, with a contact name; that is the address of record on the filing and is not presented here as a verified corporate headquarters. No parent company, brand relationship, ownership structure or affiliate is identified in the numbered sources. [1][4]
The linked collection for this company contains one 510(k) record, and the decision counts show one SESE decision. That count reflects the filings retrieved as of the snapshot date and is not a measure of total company sales, total portfolio or safety performance. No recall records are associated with the company in the retrieved data. Commercial availability, customers, certifications and clinical outcomes are not documented in these sources. [1][4]
How to read the public record
FDA.report reproduces the K254160 details, including applicant, product code, regulation, classification name, review panel, device class, clearance type, summary status and third-party review flag, and notes that its data derive from public FDA datasets and legacy records that can change. The agency's own 510(k) and TPLC pages remain the authoritative references for the decision. [4][5]

